Replicel Life Sciences Inc V.RP

Injector

[Year3000]

In September Replicel release a NR saying: 

“We have received testing data, confirming the device will function according to our designated parameters. DermaPrecise™ has illustrated its value proposition by controlling injections based on volume, depth and sheer force” Schutte stated. “We believe this comprehensive testing data will be key in business development efforts going forward.” RepliCel anticipates completing the development phase in 2023. The next step will be securing a contract manufacturer in North America

so now we are coming to the end of 2023 I wonder when we will hear from Replicel regarding the injector

[Ingiboy]

Year3000 as usual just enough of vagueness so that you don't really have any precise answers.  Do the mean completing development of the device by the end of 2023 or just sometime in 2023 which by the way is running out of time.  Securing a contract manufacturer I heard this at the AGM in September 2 1/2 months ago so that has not gone anywhere.   My disappointment is in

[toniZ1]

lol you guys impress me, still in hopes for the needle machine.

[Year3000]

There's nothing else to cheer about! 

[Ingiboy]

Why would we not be hopeful ? I don't think it is a matter of if it will be taken to market, it is when. I like you am disappointed it is not being marketed already.  As usual it is all about the lack of working capital this company has suffered for years.  This does not diminish the fact that the device has been proven to work and is virtually ready to be submitted for FDA Approval